ClinicalTrials.Veeva

Menu

Born In Guangzhou Intervention Study (BIGIS)

G

Guangzhou Women and Children's Medical Center

Status

Enrolling

Conditions

Pregnancy Complications
Child Development
Pregnancy Outcomes

Treatments

Behavioral: Lifestyle modification

Study type

Interventional

Funder types

Other

Identifiers

NCT05503849
2022390B00

Details and patient eligibility

About

The main objective of this study is to test the efficacy of an intervention package (dietary, physical and lifestyle modification) during pregnancy in improving the clinical outcomes of mother-infant dyads.

Enrollment

1,160 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant women attending prenatal care at Guangzhou Women and Children's Medical Center (GWCMC) <20 weeks' gestation
  • Pregnant women plan to deliver at GWCMC
  • Pregnant women intend to reside in Guangzhou for at least 3 years

Exclusion criteria

  • Multiple pregnancies
  • Existing medical conditions (uncontrolled diabetes, hypertension or thyroid disease; other serious cardiovascular diseases, respiratory or systematic disorders)
  • Use of drugs (aspirin, metformin, low molecular weight heparin)
  • Women with reading and/or writing difficulties
  • Women with serious mental disorders
  • Women with eating disorders

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

1,160 participants in 2 patient groups

Proactive management during pregnancy
Experimental group
Description:
A combination of dietary, physical activity and lifestyle modification.
Treatment:
Behavioral: Lifestyle modification
Standard Care
No Intervention group
Description:
No additional intervention beyond standard care procedure.

Trial contacts and locations

2

Loading...

Central trial contact

Qiu Qiu, Dr.; Songying Shen, Msc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems